Showing 20 of 90 recruiting trials for “hereditary-attr-amyloidosis”
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
RecruitingNCT06365060 ↗
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RecruitingNCT06907836 ↗
Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study
👨⚕️ Yongyong Ma, MD, First Affiliated Hospital of Wenzhou Medical University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06367842 ↗
Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
👨⚕️ Larry Anderson, MD, University of Texas Southwestern Medical Center📍 3 sites📅 Started Feb 2024View details ↗
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
RecruitingNCT06205953 ↗
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
RecruitingNCT07130565 ↗
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
RecruitingNCT06355934 ↗
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
RecruitingNCT06345235 ↗
New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis
RecruitingNCT05697861 ↗
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →